Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Screening Funds: Possible Pay-For Target For "1099" Tax Rule Repeal?

This article was originally published in The Gray Sheet

Executive Summary

While a House-approved bill to repeal the entire health care reform law will be dead-on-arrival due to Democratic control of the Senate and White House, there is some bipartisan support for reversing one unpopular provision of the reform law that requires extra tax filings by companies.

You may also be interested in...



Friendly Fire? Tavenner Nomination Held Up By Sen. Harkin

While the Senate Finance Committee April 23 agreed to endorse Marilyn Tavenner to head CMS, Sen. Tom Harkin, D-Iowa, Chairman of the Senate HELP Committee, put a block on her full Senate approval the next day.

Capitol Hill In Brief

More comparative effectiveness clashes

Capitol Hill In Brief

More comparative effectiveness clashes

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel